Compare Novavax Inc (NVAX) vs iShares 1 3 Year Treasury Bond ETF (SHY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs iShares 1 3 Year Treasury Bond ETF — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while iShares 1 3 Year Treasury Bond ETF trades at $81.9. The key difference: Novavax Inc is trading nearer its 52-week high, iShares 1 3 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals.
| NVAX | SHY | |
|---|---|---|
Market Cap | $1.30B | — |
Sector | Health | Fixed Income |
52-Week High | $11.19 | $83.18 |
52-Week Low | $6.22 | $81.79 |
Enterprise Value | $800.50M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About iShares 1 3 Year Treasury Bond ETF
SHY provides exposure to U.S. Treasury bonds with remaining maturities between one and three years. It is a low-risk, highly liquid ETF designed for capital preservation and short-term income, featuring 2026 top holdings across various Treasury Notes.
Read more on SHY →
